Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -136.77% is 77% below its 5-year average of -77.22%, near the low end of its 5-year range (-136.77%–-24.19%).
As of the fiscal period ended Wednesday, December 31, 2025. 69.94% below its 12-month average of -80.48%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-12-31.
RETURN ON INVESTED CAPITAL (ROIC)
-136.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-80.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-75.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-77.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-69.94%
CURRENT VS 3Y AVG
-80.00%
CURRENT VS 5Y AVG
-77.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
-308.27%
vs the sector median at left
Connect Biopharma Holdings Limited
Market Cap
$60.32M
Return on Invested Capital (ROIC)
-136.77%
TTM Avg
-80.48%
3Y Avg
-75.99%
5Y Avg
-77.22%
Market Cap
$60.49M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$60.17M
Return on Invested Capital (ROIC)
-1235.48%
TTM Avg
-801.38%
3Y Avg
-433.95%
5Y Avg
-312.84%
Market Cap
$61.23M
Return on Invested Capital (ROIC)
-79.68%
TTM Avg
-67.52%
3Y Avg
-59.81%
5Y Avg
-47.97%
Market Cap
$59.10M
Return on Invested Capital (ROIC)
-129.67%
TTM Avg
-97.71%
3Y Avg
-90.63%
5Y Avg
-82.49%
Market Cap
$58.34M
Return on Invested Capital (ROIC)
-604.20%
TTM Avg
-195.52%
3Y Avg
-273.84%
5Y Avg
-208.65%
Market Cap
$57.87M
Return on Invested Capital (ROIC)
-43.97%
TTM Avg
-40.46%
3Y Avg
-48.41%
5Y Avg
-43.33%
Market Cap
$63.14M
Return on Invested Capital (ROIC)
-4.72%
TTM Avg
-4.96%
3Y Avg
-2.45%
5Y Avg
-3.32%
Market Cap
$63.23M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $60.32M | -136.77% | -80.48% | -75.99% | -77.22% |
| PDS Biotechnology Corporation (PDSB)vs › | $60.49M | -3699.99% | -104.88% | -89.50% | -74.29% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.17M | -1235.48% | -801.38% | -433.95% | -312.84% |
| Adicet Bio, Inc. (ACET)vs › | $61.23M | -79.68% | -67.52% | -59.81% | -47.97% |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | -129.67% | -97.71% | -90.63% | -82.49% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.34M | -604.20% | -195.52% | -273.84% | -208.65% |
| Boundless Bio, Inc. (BOLD)vs › | $57.87M | -43.97% | -40.46% | -48.41% | -43.33% |
| InterCure Ltd. (INCR)vs › | $63.14M | -4.72% | -4.96% | -2.45% | -3.32% |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | -165.22% | -160.52% | -107.11% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.26M | -52.40% | -44.92% | -44.92% | -44.02% |
ROIC
-136.8%
ROE
-132.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -136.77% |
| 2024-12-31 | -24.19% |
| 2023-12-31 | -67.65% |
| 2022-12-31 | -75.33% |
| 2021-12-31 | -35.93% |
| 2020-12-31 | -123.42% |
| 2019-12-31 | -223.45% |
